GONUTS has been updated to MW1.31 Most things seem to be working but be sure to report problems.

Have any questions? Please email us at ecoliwiki@gmail.com

PMID:11018070

From GONUTS
Jump to: navigation, search
Citation

Zhang, ZG, Zhang, L, Jiang, Q, Zhang, R, Davies, K, Powers, C, Bruggen, N and Chopp, M (2000) VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J. Clin. Invest. 106:829-38

Abstract

VEGF is a secreted mitogen associated with angiogenesis and is also a potent vascular permeability factor. The biological role of VEGF in the ischemic brain remains unknown. This study was undertaken to investigate whether VEGF enhances cerebral microvascular perfusion and increases blood-brain barrier (BBB) leakage in the ischemic brain. Using magnetic resonance imaging (MRI), three-dimensional laser-scanning confocal microscope, and functional neurological tests, we measured the effects of administrating recombinant human VEGF(165) (rhVEGF(165)) on angiogenesis, functional neurological outcome, and BBB leakage in a rat model of focal cerebral embolic ischemia. Late (48 hours) administration of rhVEGF(165) to the ischemic rats enhanced angiogenesis in the ischemic penumbra and significantly improved neurological recovery. However, early postischemic (1 hour) administration of rhVEGF(165) to ischemic rats significantly increased BBB leakage, hemorrhagic transformation, and ischemic lesions. Administration of rhVEGF(165) to ischemic rats did not change BBB leakage and cerebral plasma perfusion in the contralateral hemisphere. Our results indicate that VEGF can markedly enhance angiogenesis in the ischemic brain and reduce neurological deficits during stroke recovery and that inhibition of VEGF at the acute stage of stroke may reduce the BBB permeability and the risk of hemorrhagic transformation after focal cerebral ischemia.

Links

PubMed PMC517814 Online version:10.1172/JCI9369

Keywords

Animals; Blood-Brain Barrier/drug effects; Brain Ischemia/physiopathology; Endothelial Growth Factors/pharmacology; Image Processing, Computer-Assisted; Lymphokines/pharmacology; Magnetic Resonance Imaging; Male; Microcirculation/drug effects; Neovascularization, Pathologic/chemically induced; Rats; Rats, Wistar; Regional Blood Flow; Stroke/drug therapy; Treatment Outcome; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

Significance

Annotations

Gene product Qualifier GO Term Evidence Code with/from Aspect Extension Notes Status

RAT:NRP1

GO:0090211: positive regulation of establishment of blood-brain barrier

ECO:0000314:

P

Figure 1g: Quantitative Data was analyzed that showed a significant amount of increase for rhVEGF165 treated group in plasma perfusion in vessels within 3μm of diameters compared to the data for saline-treated control group.

complete
CACAO 5478

RAT:NRP1

GO:0008015 : blood circulation

ECO:0000314:

P

Figure 7: A transient increase of Cerebal blood flow in the ischemic brain was observed via early administration of rhVEGF165 in rats.

complete
CACAO 5480


See also

References

See Help:References for how to manage references in GONUTS.